Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
E-Z-Disk
Overview
What is E-Z-Disk?
E-Z-DISK™ is an oral solid radiographic contrast
agent. Each tablet contains 700 mg of barium sulfate and is ½ inch
in diameter. The active ingredient is barium sulfate and its structural
formula is BaSO. Barium sulfate occurs as
a fine, white, odorless, tasteless, bulky powder which is free from
grittiness. Its aqueous suspensions are neutral to litmus. It is practically
insoluble in water, solutions of acids and alkalies, and organic solvents.
What does E-Z-Disk look like?

What are the available doses of E-Z-Disk?
Sorry No records found.
What should I talk to my health care provider before I take E-Z-Disk?
Sorry No records found
How should I use E-Z-Disk?
E-Z-DISK is indicated
for use in radiography of the esophagus, for detection of esophageal
strictures.
This tablet
is most useful in patients experiencing dysphagia, particularly in
those whose findings are deemed inconclusive by conventional methods.
The problems associated with obtaining satisfactory films exhibiting
complete filling of the pharynx and cricopharyngeal area make for
difficult diagnosis in this region. In such cases, failure of the
tablet to freely pass this site may indicate significant esophageal
disease as cause of the symptoms, and may warrant further videographic
studies.
The patient
should be instructed to swallow one tablet intact, with the aid of
one or two swallows of water, just prior to fluoroscopic examination.
Using a tablet of known diameter (½ inch) not
only illustrates the presence of a significant narrowing of the esophagus,
but also provides a simple technique to measure the lumen at the site
of the stricture. The most routinely used esophagoscope has external
diameter of 36 French, and thus a tablet of corresponding half-inch
diameter was selected. The actual diameter (in inches) of the narrow
site is one-half the ratio of its measure value on the film to the
measure of the tablet
Upon swallowing the tablet, the patient experiences
no significant discomfort, and fluid passes around the tablet without
difficulty.
What interacts with E-Z-Disk?
Barium sulfate products for radiographic procedures should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate formulations.
What are the warnings of E-Z-Disk?
Other drugs possibly affecting alprazolam metabolism by inhibition of CYP3A are discussed in the section (see : Drug Interactions).
What are the precautions of E-Z-Disk?
General
Diagnostic procedures which involve the use of
radiopaque contrast agents should be carried out under the direction
of personnel with the requisite training and with a thorough knowledge
of the particular procedure to be performed. A history of bronchial
asthma, atopy, as evidenced by hay fever and eczema, or a previous
reaction to a contrast agent, warrant special attention.
Use with caution in patients with
complete or nearly complete esophageal or gastric obstruction.
Information
For Patients
- Inform their physician if they are pregnant.
- Inform their physician if they are allergic to any drugs or food, or if they have had any prior reactions to barium sulfate products or other contrast agents used in x-ray procedures (see ).
- Inform their physician about any other medications they are currently taking.
Before administration of this product, patients receiving barium sulfate diagnostic agents should be instructed to:
Usage in Pregnancy
Radiation is known to cause harm to the unborn fetus exposed in utero. Therefore, radiographic procedures should be used only when, in the judgment of the physician, their use is deemed essential to the welfare of the pregnant patient.
Nursing Mothers
Barium sulfate products may be used during lactation.
What are the side effects of E-Z-Disk?
Sorry No records found
What should I look out for while using E-Z-Disk?
Barium sulfate products for radiographic procedures
should not be used in patients with known gastric or intestinal perforation
or hypersensitivity to barium sulfate formulations.
Rarely, severe allergic reactions of an anaphylactoid
nature have been reported following administration of barium sulfate
contrast agents. Appropriate facilities and trained personnel should
be available for emergency treatment of severe reactions and should
remain available for at least 30 to 60 minutes following administration,
since delayed reactions can occur.
What might happen if I take too much E-Z-Disk?
Sorry No Records found
How should I store and handle E-Z-Disk?
Store at 20° to 25° C (68° to 77° F) [See USP Controlled Room Temperature].Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Store at 20° to 25° C (68° to 77° F) [See USP Controlled Room Temperature].Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. E-Z-DISK™ is a white tablet with EZEM on one side and 778 on the other side and is supplied in the following manner:Bottles of 100 ½-inch diameter, flat-sided tablets; Cat. No. 778, NDC 10361-778-31
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Barium sulfate, due to its high
molecular density is opaque to x-rays and therefore acts as a positive
contrast agent for radiographic studies. Barium sulfate is biologically
inert and therefore is not absorbed or metabolized by the body, and
is eliminated unchanged from the body.
Non-Clinical Toxicology
Barium sulfate products for radiographic procedures should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate formulations.Rarely, severe allergic reactions of an anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Appropriate facilities and trained personnel should be available for emergency treatment of severe reactions and should remain available for at least 30 to 60 minutes following administration, since delayed reactions can occur.
See .
Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the requisite training and with a thorough knowledge of the particular procedure to be performed. A history of bronchial asthma, atopy, as evidenced by hay fever and eczema, or a previous reaction to a contrast agent, warrant special attention.
Use with caution in patients with complete or nearly complete esophageal or gastric obstruction.
Adverse reactions, such as nausea, vomiting, diarrhea and abdominal cramping accompanying the use of barium sulfate suspensions are infrequent, usually mild, and generally do not occur with this product. Procedural complications are rare, but may include aspiration pneumonitis, granuloma formation, intravasation, embolization and peritonitis following intestinal perforation, vasovagal and syncopal episodes, and fatalities. It is of the utmost importance to be completely prepared to treat any such occurrence.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).